BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Tiotropium Bromide

A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

290+ PubMed studies analyzed · 38 RCTs · Evidence Score: 55.8

Research Domains

Tiotropium Bromide has been studied across 9 research domains including 🫁 Respiratory, 🔬 Inflammation, 🫘 Kidney, 🛡️ Immunity, 😴 Sleep. The primary research focus is 🫁 Respiratory with 85% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tiotropium Bromide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

mepenzolate
2 shared targets
oxotremorine
2 shared targets
endo
2 shared targets
aprofene
2 shared targets
otenzepad
2 shared targets
Scopolamine
3 shared targets
carbachol
2 shared targets
pirenzepine
2 shared targets
oxotremorine
2 shared targets
4
2 shared targets
Loading evidence profile...

This evidence profile for Tiotropium Bromide is generated deterministically from 290 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.